|
|
 |
|
Viewing report
|
|
|
|
Contraceptives in the US
Mintel, June 2006
With an increasing number of generic oral contraceptives on the market, sales of condoms and oral contraceptives declined 6.1% between 2000 and 2005 (after inflation). These generic oral contraceptives can sell for as much as 80% less than brand name products.
Consumer data show that while 15% of adults use condoms, this number could increase, considering that the U.S. has the highest rate of STDs of all industrial countries. The U.S. government and many not-for-profit organizations are spending millions of dollars to promote safe sexual health and the use of condoms. Should a condom manufacturer choose to dovetail an educational marketing campaign with the government and private sector promotions to increase awareness, directed at all sectors, sales increases could be the result.
New product development is the primary market strategy of pharmaceutical companies, in particular, development of products with added health benefits like acne prevention and pre-menopausal relief. Condom manufacturers also have new products and are developing marketing campaigns to catch the attention of younger and higher risk consumers.
Several other factors are impacting sales in the market, including a declining female population of prime childbearing years. However, some of those challenges are offset by other factors, such as the reduced number of children being born and the increased number of women delaying childbirth or deciding against having children altogether. For condom manufacturers, two hurdles are increasing awareness of STD prevention among consumers and successfully promoting an increased-sensitivity condom.
This report clearly identifies the principal external factors driving or curtailing growth. Exclusive consumer research reveals the attitudes, needs and behavior of consumers, with analysis broken down both by demographic characteristics, and by segment.
Six years of specific sales data provide a factual and impartial presentation of the market as a whole. The report also evaluates the performance of individual sectors in the market, and provides information about the major companies and brands. Using the SPSS forecasting package, a five-year forecast of U.S. retail sales is created, revealing potential opportunities for growth and product development.
The contraceptive market is defined as including all products used for birth control or as prophylactics in sexual relationships. Included are non-permanent forms of contraception: oral contraceptives, chemical, barrier and hormone-releasing implant methods, whether available over-the-counter or on prescription. This includes male and female condoms, spermicides, diaphragms/caps, oral contraceptives (birth control pills), intra-uterine devices, and injections. Natural methods of birth control or permanent contraceptives such as tubaligation and vasectomy procedures are referred to in order to indicate trends within the market, but are not included in the market size.
This report contains US IRI InfoScan data.
Customers who bought this item also bought
Oral Contraceptives & Condom Market: An Analysis
Contraceptives - Global Strategic Business Report
Contraceptives in the United States 2008
Condoms - Global Strategic Business Report
Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge
Condoms - A World Market Review
Condoms - A World Market Review
Women's Health Series: How Have New Oral Contraceptives Changed the Market?
The 2009 World Forecasts of Rubber Sheath Contraceptives (Condoms) Export Supplies
The 2009 World Market Forecasts for Imported Rubber Sheath Contraceptives (Condoms)
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
The 2009-2014 Outlook for Condoms in India
|
|
|
|
